SureTrader Nadex Advertisement Interactive Brokers Advertisement SureTrader
Home > Boards > US OTC > Medical - Equipment >

Imaging3, Inc. (IGNG)

IGNG RSS Feed
Add IGNG Price Alert      Hide Sticky   Hide Intro
Moderator: stockmasterflash
Search This Board: 
Last Post: 5/23/2017 7:03:08 PM - Followers: 257 - Board type: Free - Posts Today: 0

Imaging3 Inc.
3200 West Valhalla Drive
Burbank, CA 91505
United States - http://maps.yahoo.com/maps_result?addr=3200%20West%20Valhalla%20Drive&csz=Burbank%20CA%2091505&country=United%20States" rel="nofollow">Map
Phone: 818-260-0930
Fax: 818-260-0445
Website: http://www.imaging3.com


http://www.sec.gov/news/press/2013/2013-117.htm

http://www.sec.gov/litigation/complaints/2013/comp-pr2013-117.pdf


SEC Charges Medical Imaging Device Company and Its CEO with Fraud
FOR IMMEDIATE RELEASE
2013-117

Washington, D.C., June 26, 2013 — The Securities and Exchange Commission today announced that it filed fraud charges on Tuesday against Burbank, Calif.-based Imaging3, Inc., and its founder and chief executive Dean Janes for misleading shareholders about the Federal and Drug Administration (FDA)’s view of the company’s medical device.
Additional Materials

SEC Complaint

The SEC’s complaint alleges that Janes held a conference call with investors in November 2010 after the FDA denied clearance for Imaging3, Inc. to market its proprietary scanner, which provides three-dimensional images for use in medical diagnosis. The denial was the product’s third, as the FDA denied clearance in 2008 and earlier in 2010. Even though the FDA cited concerns about the safety of the device and the quality of the images, Janes told investors that the FDA’s issues were “not substantive” and largely “administrative.”

“Shareholders have a right to trust corporate officers to tell them the truth about the business. When CEOs abuse that trust and make misstatements, innocent shareholders are victimized,” said Michele Wein Layne, Regional Director of the SEC’s Los Angeles Regional Office. “The SEC will hold corporate officers accountable for misleading shareholders.”

According to the SEC’s complaint, filed in the U.S. District Court for the Central District of California, on the conference call, Janes did not discuss the issues raised by the FDA in an October 2010 letter, such as the device’s potential for over-heating, and the fact that some sample images the company submitted were “scientifically invalid and useless.”

Even when asked on the call whether any of the FDA’s concerns were “safety-related” or involved image quality, Janes said, “Nope,” and that there was “really and honestly not one question about the technology or its consistency. It just doesn’t make sense to me.”

After an investor obtained the FDA’s denial letter and posted it on an Internet blog in early 2011, Janes used his personal Facebook page in another effort to mischaracterize the denial, the SEC alleged. Janes and his company didn’t officially issue the full text of the denial letter until earlier this year, more than two years after the call to discuss it.

The SEC's action charges Imaging3, Inc. and Janes with fraud and seeks a court order to bar them from future violations of federal securities laws, require them to pay civil monetary penalties, and bar Janes from serving as a public company officer or director.

Alka Patel and Katharine Zoladz of the Los Angeles Regional Office conducted the SEC’s investigation and David Van Havermaat will lead the litigation.
 




Wells Notice Served on Dean Janes and Imaging3, Inc.
(Excerpt from Bankruptcy Doc 178)
Wells Notice Served by Securities Exchange Commission
On November 14, 2012, the staff of the Securities and Exchange Commission (the "SEC" or "Commission") served Wells notices on the Debtor and Dean Janes, the Debtor's CEO. The Wells notices stated that the staff of the Commission was considering recommending that the Commission bring an action against the Debtor and Janes for alleged violations of Section 10(b)of the Securities Exchange Act of 1934 (the "Exchange Act") and Rule 10b-5 thereunder, against the Debtor under Section 13(a) of the Exchange Act and Regulation FD thereunder, and against Janes for aiding and abetting the Debtor's alleged violation of Section 13(a) of the Exchange Act and Regulation FD thereunder. The staff of the Commission advised counsel for the Debtor and Janes that they were considering recommending that the Commission file an enforcement action against the Debtor and Janes to seek various penalties and remedies, including monetary penalties, a director and officer bar for Janes, and injunctive relief preventing further violations. The Debtor and Janes responded to the Wells notice on December 13, 2012, asserting that the Debtor and Janes did not violate federal securities laws and that no grounds for penalties exist. While the Commission has not yet filed suit, the matter remains ongoing, and the Debtor cannot predict the likelihood of an adverse outcome.
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
IGNG
Current Price
Volume:
Bid Ask Day's Range
IGNG News: Post-effective Amendment to Registration Statement (pos Am) 05/24/2017 06:05:36 AM
IGNG News: Withdrawal of Registration Statement (rw) 05/22/2017 05:29:12 PM
IGNG News: Quarterly Report (10-q) 05/22/2017 06:19:35 AM
IGNG News: Notification That Quarterly Report Will Be Submitted Late (nt 10-q) 05/12/2017 03:26:34 PM
IGNG News: Amended Annual Report (10-k/a) 05/09/2017 11:28:11 AM
PostSubject
#53059  Sticky Note MoneyTV and Don Baillargeon put Dean and Imaging3 stockmasterflash 01/11/17 02:37:05 PM
#47376  Sticky Note Everyone needs to get back on topic about IH Linda (Retired) 09/19/11 06:15:06 PM
#53453   Did Dean Janes ever get his funky x-ray Boxsterfan 05/23/17 07:03:08 PM
#53452   Here are the facts surrounding the expiration of simply_cynical 05/14/17 01:50:01 PM
#53451   If Dean James is not the CEO now look1 05/13/17 03:13:51 PM
#53450   must have gave igng some mmmMONEY I think look1 05/13/17 02:54:38 PM
#53449   In the in the $IGNG Bankruptcy filing stockmasterflash 05/09/17 05:10:32 PM
#53448   Sep 17, 2015 FPAY Fee payment stockmasterflash 05/09/17 05:08:41 PM
#53447   Toms River Surgery Center LLC vs. Imaging 3 stockmasterflash 05/09/17 04:52:22 PM
#53446   Wouldn't this be bankruptcy fraud by IGNG Imaging3? stockmasterflash 05/09/17 04:35:34 PM
#53445   From the PR you posted stockmasterflash 05/09/17 01:32:54 PM
#53444   Imaging3 Explains Its Most Recent 10-K Amendment MrCheap 05/09/17 01:23:38 PM
#53443   No worries. North we shall go, let's be MazelMan 05/09/17 12:52:28 PM
#53442   A patent that a creditor has had control of stockmasterflash 05/09/17 12:34:02 PM
#53441   New pr out ..just now we do have MADDSTACKER 05/09/17 12:27:30 PM
#53440   You forgot to add the Assignor -- IMAGING3, INC. ndforlife 05/09/17 12:10:47 PM
#53439   Well thats good for Toms River surgery center stockmasterflash 05/09/17 12:01:01 PM
#53438   I thought Dean had filed a new patent.. ndforlife 05/09/17 11:59:02 AM
#53437   BOOM PATENT .. MADDSTACKER 05/09/17 11:29:57 AM
#53436   Get in now! Before who MADE MONEY look1 05/05/17 11:36:10 AM
#53435   Touch o green $IGNG MrCheap 05/05/17 10:40:17 AM
#53434   Just a trader bud .. MADDSTACKER 05/03/17 07:37:42 PM
#53433   Where do they find you guys? FormerMarine 05/03/17 07:36:42 PM
#53432   Vndm gone ..let's goooo MADDSTACKER 05/03/17 11:45:05 AM
#53430   Reinstating Patents After Failure to Pay Maintenance Fee stockmasterflash 05/01/17 06:56:16 AM
#53429   Look at the very bottom of the page stockmasterflash 05/01/17 05:57:27 AM
#53428   PATENT US20040042588 is Imaging3 new patent updated patent look1 04/30/17 10:21:13 PM
#53427   Wow a penny stock that has no patent mr_sano 04/30/17 12:54:06 PM
#53425   No The assets of the company were mortgaged to stockmasterflash 04/27/17 07:15:06 PM
#53424   remember, Imaging3 allowed the patent to lapse???? look1 04/27/17 07:08:01 PM
#53423   It expired 8 years ago. stockmasterflash 04/27/17 02:00:47 PM
#53422   Lol ok they pay fee and it's reinstated MADDSTACKER 04/27/17 01:57:48 PM
#53421   Wrong. they let the patent expire stockmasterflash 04/27/17 01:54:20 PM
#53420   Ps there patent is good for another 10years MADDSTACKER 04/27/17 01:44:46 PM
#53419   Ok bud not here to argue with you MADDSTACKER 04/27/17 01:42:30 PM
#53418   Oh, I agree stockmasterflash 04/27/17 01:38:54 PM
#53417   CriTech Research makes sure your medical device uses MADDSTACKER 04/27/17 01:34:37 PM
#53416   Lawsuit went to Supreme Court Looks like all over MADDSTACKER 04/27/17 01:32:03 PM
#53415   To run the same scam stockmasterflash 04/27/17 01:30:48 PM
#53414   What think all testing was just done for MADDSTACKER 04/27/17 01:24:55 PM
#53413   To do a 510k application stockmasterflash 04/27/17 01:22:32 PM
#53412   They don't do clinical trials 510 Application MADDSTACKER 04/27/17 12:59:12 PM
#53411   A) But no clinical trials have been performed stockmasterflash 04/27/17 11:46:52 AM
#53410   I think it's very undervalued ... MADDSTACKER 04/27/17 10:29:34 AM
#53409   What I like about this is the Dr. look1 04/27/17 10:25:39 AM
#53408   CriTech Research Concludes Software Remediation on SmartScan™ Software MADDSTACKER 04/27/17 09:46:29 AM
#53407   Imaging3 Announces MoneyTV’s Interview of Scott Pancoast to MADDSTACKER 04/27/17 09:46:05 AM
#53406   Debt restructured Ready file 510 Then sales !!!! MADDSTACKER 04/27/17 09:39:35 AM
#53405   BOTTOMS UP ... LETS GOOOOOOOO MADDSTACKER 04/27/17 09:34:05 AM
#53404   Lol! Too funny!! mr_sano 04/18/17 03:20:11 AM
#53403   Just a minor "accidental" omission stockmasterflash 04/17/17 12:02:56 PM
#53402   For your new bees if they get fda look1 04/11/17 08:05:56 PM
PostSubject